Your browser doesn't support javascript.
loading
FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications".
Akbar, Mohammad; Berry-Bibee, Erin; Blithe, Diana L; Day, Ruth S; Edelman, Alison; Höchel, Joachim; Jamshidi, Roxanne; Kim, Myong-Jin; Li, Li; Purohit, Vivek S; Turpin, Jim A; Scott, Pamela E; Strauss, David G; Sun, Haiying; Tepper, Naomi K; Zhang, Lei; Yu, Chongwoo.
Afiliação
  • Akbar M; Office of Clinical Pharmacology, Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD, USA.
  • Berry-Bibee E; Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Blithe DL; Division of Reproductive Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Day RS; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, MD, USA.
  • Edelman A; Medical Cognition Laboratory, Duke University, Durham, NC, USA.
  • Höchel J; Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
  • Jamshidi R; Clinical Pharmacology, Bayer AG, Berlin, Germany.
  • Kim MJ; Department of Obstetrics and Gynecology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
  • Li L; Office of Clinical Pharmacology, Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD, USA.
  • Purohit VS; Office of Clinical Pharmacology, Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD, USA.
  • Turpin JA; Clinical Pharmacology, Pfizer, New London, CT, USA.
  • Scott PE; Prevention Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD, USA.
  • Strauss DG; Office of Women's Health (OWH), Office of the Commissioner, FDA, Silver Spring, MD, USA.
  • Sun H; Office of Clinical Pharmacology, Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD, USA.
  • Tepper NK; Novartis Institutes for Biomedical Research, East Hanover, NJ, USA.
  • Zhang L; Division of Reproductive Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Yu C; Office of Clinical Pharmacology, Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD, USA.
J Clin Pharmacol ; 58(12): 1655-1665, 2018 12.
Article em En | MEDLINE | ID: mdl-30144093
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Saúde Pública / Anticoncepcionais Femininos / Desenvolvimento de Medicamentos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Saúde Pública / Anticoncepcionais Femininos / Desenvolvimento de Medicamentos Idioma: En Ano de publicação: 2018 Tipo de documento: Article